home / stock / anip / anip news


ANIP News and Press, ANI Pharmaceuticals Inc. From 08/08/22

Stock Information

Company Name: ANI Pharmaceuticals Inc.
Stock Symbol: ANIP
Market: NASDAQ
Website: anipharmaceuticals.com

Menu

ANIP ANIP Quote ANIP Short ANIP News ANIP Articles ANIP Message Board
Get ANIP Alerts

News, Short Squeeze, Breakout and More Instantly...

ANIP - ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q2 2022 Results - Earnings Call Transcript

ANI Pharmaceuticals, Inc. (ANIP) Q2 2022 Earnings Conference Call August 8, 2022 08:00 ET Company Participants Lisa Wilson - Investor Relations Nikhil Lalwani - President & Chief Executive Officer Steve Carey - Chief Financial Officer, Senior Vice President o...

ANIP - ANI Pharma stock rises on Q2 revenue beat, in-line 2022 forecast

ANI Pharma ( NASDAQ: ANIP ) is trading 2.5% higher after the company reported better-than-expected Q2 revenue and 2022 guidance that was in-line with estimates., helped by higher sales of purified cortrophin Gel and generic pharmaceuticals. The company reite...

ANIP - ANI Pharmaceuticals Q2 mixed earnings; raises FY 2022 revenue guidance for Cortrophin

ANI Pharmaceuticals press release ( NASDAQ: ANIP ): Q2 Non-GAAP EPS of $0.13 misses by $0.09 . Revenue of $73.9M (+52.0% Y/Y) beats by $1.93M . Adjusted non-GAAP EBITDA of $9.9M. Full-Year 2022 Guidance : Reiterates total company net revenue guidan...

ANIP - ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel

Second Quarter 2022 Results: -- Net revenues of $73.9 million, net loss available to common shareholders of $(15.3) million and diluted GAAP loss per share of $(0.94) – -- Lead Rare Disease asset, Purified Cortrophin ® Gel (Repository Cortic...

ANIP - ANI Pharmaceuticals Q2 2022 Earnings Preview

ANI Pharmaceuticals ( NASDAQ: ANIP ) is scheduled to announce Q2 earnings results on Monday, August 8th, before market open. The consensus EPS Estimate is $0.22 (-67.2% Y/Y) and the consensus Revenue Estimate is $71.97M (+48.0% Y/Y). Over the last 2 years, ANIP has b...

ANIP - Notable earnings before Monday's open

ANIP , APRN , ASRT , BNTX , CLVS , D , DCTH , DTIL , ELAN , ENR , FREY , GOLD , HE , HEP , ITUB , KNDI , KOS , LINC , OTCPK:LKNCY , OSG , PDSB , PLTR , PRTY , RDWR , RETA , SOHU , TGN...

ANIP - ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Acebutolol Hydrochloride Capsules. ANI’s Acebutolol Hydrochloride Capsules are the generic version of the Reference Listed Drug (RLD) Sectral ® ...

ANIP - ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the purchase of four abbreviated new drug applications (ANDAs) from Oakrum Pharma, LLC, a privately owned biopharmaceutical company. “We are pleased to expand our generics product portfolio with the...

ANIP - ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2022 financial results on Monday, August 8, 2022, prior to market open. Nikhil Lalwani, President and Chief Executive Office...

ANIP - What Stocks to Invest Today? 3 Pharmaceutical Stocks To Watch

3 Pharmaceutical Stocks For Your Watchlist Right Now For investors wondering what are the best stocks to invest in today, pharmaceutical stocks would be an interesting play. On the whole, this part of the stock market is home to companies of varying sizes and specializations...

Previous 10 Next 10